| Glucose 10% w/v Solution for Infusion PA2059/040/007 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Glucose 10% w/v Solution for Infusion PA2059/040/008 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Glucose 10% w/v Solution for Infusion PA2059/040/010 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Glucose 10% w/v Solution for Infusion PA2299/003/002 |
Glucose |
Baxter Holding B.V. |
Marketed |
| Glucose 5% w/v Intravenous Infusion BP, polyolefin/polyamide bag PA2299/003/001 |
Glucose |
Baxter Holding B.V. |
Marketed |
| Glucose 5% w/v Solution for Infusion PA2059/040/001 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Glucose 5% w/v Solution for Infusion PA2059/040/003 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Glucose 5% w/v Solution for Infusion PA2059/040/004 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Glucose 5% w/v Solution for Infusion PA2059/040/009 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Glucose 5% w/v, Solution for Infusion PA2059/040/002 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Glucose 50% w/v sterile concentrate, concentrate solution for infusion PA0179/001/039 |
Anhydrous glucose |
B. Braun Medical Limited |
Marketed |
| Glucose Intravenous Infusion BP 10% w/v, solution for infusion PA0179/001/028 |
Anhydrous glucose |
B. Braun Medical Limited |
Marketed |
| Glucose Intravenous Infusion BP 5% w/v solution for infusion PA0179/001/003 |
Glucose |
B. Braun Medical Limited |
Marketed |
| Glycerol 1g Suppositories PA0549/028/001 |
Glycerol |
Ethypharm |
Not marketed |
| Glycerol 4g Suppositories PA0549/028/003 |
Glycerol |
Ethypharm |
Marketed |
| Glyceryl Trinitrate 5 mg/ml Sterile Concentrate PA0822/204/001 |
Glyceryl trinitrate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Glycopyrronium bromide 200 micrograms/ml Solution for injection PA0549/029/001 |
Glycopyrronium bromide |
Ethypharm |
Not marketed |
| Glycopyrronium Bromide 200 micrograms/ml Solution for Injection PA0857/001/001 |
Glycopyrronium bromide |
MercuryPharm Ltd |
Marketed |
| Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per ml Solution for Injection PA0857/002/001 |
Glycopyrronium bromide, Neostigmine Metilsulfate |
MercuryPharm Ltd |
Marketed |
| GLYPRESSIN 1 mg Powder and Solvent for Solution for Injection PA1009/004/001 |
Terlipressin acetate |
Ferring Ireland Ltd |
Marketed |
| Glypressin 1 mg/ 8.5 ml solution for injection PA1009/004/002 |
Terlipressin acetate |
Ferring Ireland Ltd |
Marketed |
| Glytrin 400 micrograms per metered dose Sublingual Spray PA2262/004/001 |
Glyceryl trinitrate |
Evolan Pharma AB |
Not marketed |
| Glyxambi 10 mg/5 mg film-coated tablets EU/1/16/1146/001-009 |
Empagliflozin, Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| Glyxambi 25 mg/5 mg film-coated tablets EU/1/16/1146/010-018 |
Empagliflozin, Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| GOBIVAZ 100 mg solution for injection in pre-filled pen EU/1/25/1988/005-006 |
Golimumab |
Advanz Pharma Limited |
— |
| GOBIVAZ 100 mg solution for injection in pre-filled syringe EU/1/25/1988/007-008 |
Golimumab |
Advanz Pharma Limited |
— |
| GOBIVAZ 50 mg solution for injection in pre-filled pen EU/1/25/1988/001-002 |
Golimumab |
Advanz Pharma Limited |
— |
| GOBIVAZ 50 mg solution for injection in pre-filled syringe EU/1/25/1988/003-004 |
Golimumab |
Advanz Pharma Limited |
— |
| Gohibic 200 mg Concentrate for solution for infusion EU/1/24/1884/001 |
Vilobelimab |
InflaRx GmbH |
— |
| Golden Eye 0.1% w/v Eye drops, solution PA22695/001/001 |
Propamidine isetionate |
Cambridge Healthcare Ireland Limited |
Marketed |
| Golden Eye 0.15% w/w Eye Ointment PA22695/001/002 |
Dibromopropamidine isethionate |
Cambridge Healthcare Ireland Limited |
Marketed |
| Gonal-F EU/1/95/001/023 |
Follitropin alfa |
Serono Limited |
— |
| Gonal-F EU/1/95/001/024 |
Follitropin alfa |
Serono Limited |
— |
| Gonal-F EU/1/95/001/025 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F EU/1/95/001/026 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F EU/1/95/001/027 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F EU/1/95/001/028 |
Follitropin alfa |
Serono Limited |
— |
| Gonal-F EU/1/95/001/029 |
Follitropin alfa |
Serono Limited |
— |
| Gonal-F EU/1/95/001/031 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F 1050 IU/1.75 mL powder and solvent for solution for injection EU/1/95/001/021 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F 300 IU/0.48 mL solution for injection in pre-filled pen EU/1/95/001/033 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F 450 IU/0.72 mL solution for injection in pre-filled pen EU/1/95/001/034 |
Follitropin alfa |
Merck Europe B.V. |
— |
| GONAL-f 900 IU/1.44 mL solution for injection in pre-filled pen EU/1/95/001/035 |
Follitropin alfa |
Merck Europe B.V. |
— |
| GoResp Digihaler 160 microgram/4.5 microgram inhalation powder EU/1/19/1403/001-003 |
Budesonide, Formoterol fumarate dihydrate |
Teva Pharma B.V. |
— |
| GoResp Digihaler 320 microgram/9 microgram inhalation powder EU/1/19/1403/004-005 |
Budesonide, Formoterol fumarate dihydrate |
Teva Pharma B.V. |
— |
| Gotenfia 100 mg solution for injection in pre-filled syringe EU/1/25/2009/003-004 |
Golimumab |
Stada Arzneimittel AG |
— |
| Gotenfia 50 mg solution for injection in pre-filled syringe EU/1/25/2009/001-002 |
Golimumab |
Stada Arzneimittel AG |
— |
| Grafalon 20 mg/ml concentrate for solution for infusion PA1015/001/001 |
Anti-human t-lymphocyte immunoglobulin from rabbits |
Neovii Biotech GmbH |
Marketed |
| GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe PA22641/002/002 |
Lenograstim |
Chugai Pharma France |
Marketed |
| GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe PA22641/002/001 |
Lenograstim |
Chugai Pharma France |
Marketed |